Streamline Health Solutions, Inc. (STRM)
NASDAQ: STRM · Real-Time Price · USD
3.390
+0.240 (7.62%)
At close: Dec 20, 2024, 4:00 PM
3.220
-0.170 (-5.01%)
After-hours: Dec 20, 2024, 4:42 PM EST
STRM Revenue
Streamline Health Solutions had revenue of $4.42M in the quarter ending October 31, 2024, a decrease of -27.95%. This brings the company's revenue in the last twelve months to $18.59M, down -22.49% year-over-year. In the fiscal year ending January 31, 2024, Streamline Health Solutions had annual revenue of $22.60M, down -9.21%.
Revenue (ttm)
$18.59M
Revenue Growth
-22.49%
P/S Ratio
0.72
Revenue / Employee
$241,390
Employees
77
Market Cap
14.46M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jan 31, 2024 | 22.60M | -2.29M | -9.21% |
Jan 31, 2023 | 24.89M | 7.51M | 43.21% |
Jan 31, 2022 | 17.38M | 6.03M | 53.17% |
Jan 31, 2021 | 11.35M | -507.00K | -4.28% |
Jan 31, 2020 | 11.85M | -10.51M | -47.00% |
Jan 31, 2019 | Pro | Pro | Pro |
Jan 31, 2018 | Pro | Pro | Pro |
Jan 31, 2017 | Pro | Pro | Pro |
Jan 31, 2016 | Pro | Pro | Pro |
Jan 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Marinus Pharmaceuticals | 31.47M |
Lifeward | 25.00M |
Ekso Bionics Holdings | 17.68M |
ImmunoPrecise Antibodies | 17.27M |
BioXcel Therapeutics | 2.28M |
Kazia Therapeutics | 1.66M |
Innovative Eyewear | 1.56M |
GlycoMimetics | 10.00K |
STRM News
- 3 days ago - Streamline Health® Expands Presence In Texas with 400-Bed Health System for RevID - GlobeNewsWire
- 4 days ago - Streamline Health Solutions, Inc. (STRM) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 5 days ago - Streamline Health® Reports Fiscal Third Quarter 2024 Financial Results, Accelerates Anticipated Adjusted EBITDA Breakeven Timeline - GlobeNewsWire
- 12 days ago - Streamline Health® To Report Fiscal Third Quarter 2024 Financial Performance - GlobeNewsWire
- 6 weeks ago - Streamline Health® Announces New eValuator™ Contract With Texas-Based Health System - GlobeNewsWire
- 7 weeks ago - Streamline Health® Adds Quality Module to Third eValuator™ Client - GlobeNewsWire
- 2 months ago - Streamline Health® Adds Quality Module to Existing eValuator Relationship - GlobeNewsWire
- 2 months ago - Streamline Health® Debuts eValuator™ Quality Module - GlobeNewsWire